Tag: 2026
AstraZeneca Advances Oral GLP-1 Elecoglipron to Phase III Programme
AstraZeneca announced positive results from the VISTA and SOLSTICE Phase IIb trials of elecoglipron, an investigational oral small molecule glucagon-like peptide-1 receptor agonist (GLP-1 RA). The data,...
ICMR Study Focuses on Vitamin Intake and Diet Diversity
A groundbreaking community-based study conducted by the ICMR-National Institute of Nutrition (ICMR-NIN) has established a significant connection between poor micronutrient status and a higher...
Roche Enters BTK Degrader Space with $2.3B Nurix Therapeutics Alliance
Roche and Nurix Therapeutics, Inc. announced a definitive global licensing and collaboration agreement to co-develop and co-commercialize bexobrutideg (NX-5948), an investigational, orally bioavailable Bruton’s Tyrosine Kinase (BTK) degrader. The transaction, valued...
CDSCO Tightens Action Against Banned Antibiotics After Shrimp Export Rejections Jump 43%
The Central Drugs Standard Control Organisation (CDSCO), under India's Ministry of Health and Family Welfare, has issued a directive to all State and Union...
Nepal Seeks IIT and AIIMS Campuses to Adopt India’s Success Path
In a landmark move to redefine bilateral cooperation, Nepal’s Minister for Foreign Affairs, Shisir Khanal, has formally proposed the establishment of Indian Institute of...
West Bengal Becomes 36th State to Implement Ayushman Bharat PM-JAY, Covering 1.43 Crore Families
West Bengal officially joined the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY) on Monday, becoming the 36th State/UT to implement India's flagship...
